نتایج جستجو برای: radiosensitizer

تعداد نتایج: 575  

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2006
F Mornex N Girard

Stage III non-small cell lung cancer (NSCLC) treatment is evolving. There are several choices available regarding which chemotherapy to use and how to optimally combine them with radiotherapy. Gemcitabine (Gemzar, Eli Lilly and Company, Indianapolis, USA) is a chemotherapeutic agent with activity in NSCLC, and preclinical studies have shown that gemcitabine is a potent radiosensitizer. These tw...

Journal: :iranian journal of cancer prevention 0
mostafa rezaei-tavirani elham dolat hadi hasanzadeh samaneh-sadat seyyedi vahid semnani sara sobhi

abstract background: radiosensitizer drugs are used to enhance the efficiency of radiotherapy. some nanoparticles can be considered as radiosensitizers, because they enhance cytotoxicity due to oxidative stress and increase free radical yield, especially ros , within cells resulting to cell death. methods: in this study, synergistic effect of tio 2 nanoparticles was evaluated in presence of 60 ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2001
R A Wolff D B Evans D M Gravel R Lenzi P W Pisters J E Lee N A Janjan C Charnsangavej J L Abbruzzese

Gemcitabine has modest activity in the treatment of advanced pancreatic cancer and is a potent radiosensitizer. We conducted a Phase I trial to determine the maximum tolerated dose of weekly gemcitabine delivered concurrently with radiation therapy for the treatment of locally advanced adenocarcinoma of the pancreatic head and to assess the treatment-related toxic effects associated with such a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید